US Population-Based Longitudinal Survey in Migraine: ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/40122
• EU PAS number:
  EUPAS36296
• Study ID:
  40122
• Official title and acronym:
  US Population-Based Longitudinal Survey in Migraine: ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study status:
  Ongoing

Research institution and networks

Institutions

Kantar Health

Study timelines

Date when funding contract was signed

Actual: 29/03/2018

Study start date

Actual: 21/09/2018

Date of final study report

Planned: 30/06/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company

Study protocol

Initial protocol

2017-6229 US OVERCOME_Changes for Cohort 3 02Nov2020_Amendment(c)_Approved 11NOV2020 (1)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable